Atlas Trials

Qing Su

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Qing Su

RecordFirmDate
The Impact of Nicotinamide Mononucleotide Sustained-release Tablets on Immunosenescence and Metablism in Middle-aged and Elderly Individuals With Metabolic Disorders. (NCT06907329)Qing Su2025-06-05

Track Qing Su automatically

Every clearance here is in the API, with alerts when new ones post.